Monoclonal antibody in the treatment of multiple myeloma

iStock_000025815091_Full (1)Multiple myeloma (MM) is considered to be an incurable disease. However, with the release of Daratumumab by the US FDA in November 2015 there is a real hope for patients suffering from this chronic disease. The drug was registered for patients with MM in whom the use of elementary line treatment, with the proteasome inhibitor (PI) and an immunomodulating agent, was ineffective.

Read full text »

Long-chain fatty acids may cause exacerbation of multiple sclerosis

iStock_000034378286_FullScientists from Friedrich-Alexander-University Erlangen-Nuremberg and Ruhr University Bochum in Germany conducted a research which showed that intestinal flora, as well as the type of fatty acids in the daily diet, through the influence on the cells of the immune system have an impact on exacerbation of multiple sclerosis. The results of the study were published in “Immunity” magazine. Read full text »

Breastfeeding by mothers suffering from multiple sclerosis may prevent the development of the disease and the occurrence of new metastasis

iStock_000019071669_FullFor many years it was thought that women suffering from multiple sclerosis should not decide to become mothers because of the risk of worsening of their condition. Postnatal period was regarded as one of the risk factors of new relapses. German researchers conducted a study and its aim was to compare the disease in the postnatal period in women who exclusively breastfed, with those who breastfed partially or not fed at all. The latest results published in the journal JAMA Neurology by a group of researchers at the Ruhr-University Bochum in Germany demonstrate that breastfeeding may prevent the development of the disease in women after childbirth.

Read full text »

Drinking coffee reduces the risk of multiple sclerosis?

Brain Specimen and StethoscopeResults of studies which suggest that drinking coffee may reduce the risk of multiple sclerosis (MS) development were presented during the 67th annual symposium of the American Academy of Neurology in Washington. Read full text »

Helicobacter pylori infection and the prevalence of multiple sclerosis

iStock_000016507590XSmallMultiple sclerosis (Multiple sclerosis – MS) is a chronic, inflammatory autoimmune disorder of the central nervous system. The prevalence of MS varies from 2 to 150 patients per 100 000 inhabitants, depending on geographic region. The first symptoms usually appear between 20 and 40 years of age. It occurs twice as often in women than in men. Potential causes of multiple sclerosis include genetic, environmental or infectious factors. New study published in the Journal of Neurology, Neurosurgery & Psychiatry suggested a potential link between Helicobacter pylori infection and the prevalence of multiple sclerosis.

Read full text »

New treatment of multiple sclerosis at hand

Multiple sclerosis (MS) is a chronic inflammatory disease that involves a destruction of central nervous system’s axons. The destructive process affects neurons, oligodendrocytes and microglia. The disease leads to a progressive disability. Researchers at Northwestern University in the U.S. have created biodegradable nanoparicles that may provide a mean of transport for antigens. The antigens proved to have an ability to halt the immune system from destroying myelin sheaths of the neurons. Studies performed on laboratory rodents have shown the effectiveness of the method in the fight against remitting-relapsing multiple sclerosis. Read full text »